Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

André Grimaldi

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
La Revue Du Praticien|June 23, 2007
[Type 2 diabetes of the adult]André Grimaldi
La Revue Du Praticien|December 2, 2015
[Is hypoglycemia dangerous in type 2 diabetes?]André Grimaldi
La Revue Du Praticien|May 15, 2010
[Hyperglycemia and cardiovascular risk: lessons from randomized trials]André Grimaldi
Soins; La Revue De Reference Infirmiere|May 5, 2005
[Acceptance of diabetes in the adult: what is the truth?]André Grimaldi
La Revue Du Praticien|December 6, 2018
An example of clinical controversy related to evidence-based medecineAndré Grimaldi
La Revue Du Praticien|July 9, 2003
[Type 2 diabetes: the epidemic is at hand]André Grimaldi
La Revue Du Praticien|May 15, 2010
[Trends in type 2 diabetes]André Grimaldi
La Revue Du Praticien|December 5, 2018
[Why to choose metformin as first line treatment in type2 diabetes? The answer is simple!]André Grimaldi
Biochimie|March 1, 2005
Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?Paul André Grimaldi
Sante Publique (Vandoeuvre-Les-Nancy, France)|October 16, 2007
[Patient education and disease management]François Bourdillon, André Grimaldi
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
La Revue Du Praticien|June 23, 2007
[Type 2 diabetes of the adult]André Grimaldi
La Revue Du Praticien|December 2, 2015
[Is hypoglycemia dangerous in type 2 diabetes?]André Grimaldi
La Revue Du Praticien|May 15, 2010
[Hyperglycemia and cardiovascular risk: lessons from randomized trials]André Grimaldi
Soins; La Revue De Reference Infirmiere|May 5, 2005
[Acceptance of diabetes in the adult: what is the truth?]André Grimaldi
La Revue Du Praticien|December 6, 2018
An example of clinical controversy related to evidence-based medecineAndré Grimaldi
La Revue Du Praticien|July 9, 2003
[Type 2 diabetes: the epidemic is at hand]André Grimaldi
La Revue Du Praticien|May 15, 2010
[Trends in type 2 diabetes]André Grimaldi
La Revue Du Praticien|December 5, 2018
[Why to choose metformin as first line treatment in type2 diabetes? The answer is simple!]André Grimaldi
Biochimie|March 1, 2005
Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?Paul André Grimaldi
Sante Publique (Vandoeuvre-Les-Nancy, France)|October 16, 2007
[Patient education and disease management]François Bourdillon, André Grimaldi
Pageof 3